{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:02:59Z","timestamp":1778878979091,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031580","name":"National Vaccine Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004192","name":"National Science and Technology Development Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004776","name":"Faculty of Medicine, Chulalongkorn University","doi-asserted-by":"publisher","award":["RA-MF-06\/67"],"award-info":[{"award-number":["RA-MF-06\/67"]}],"id":[{"id":"10.13039\/501100004776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2026.119037","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T19:59:17Z","timestamp":1769198357000},"page":"119037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Preclinical evaluation of DENV1 mRNA vaccines in mice: Toward improved neutralizing antibody and T cell responses"],"prefix":"10.1016","volume":"195","author":[{"given":"Chirayus","family":"Khawsang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7565-9211","authenticated-orcid":false,"given":"Eakachai","family":"Prompetchara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supichcha","family":"Saithong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kittipan","family":"Tharakhet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Papatsara","family":"Kaewpang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nongnaphat","family":"Yostrerat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pachara","family":"Wangsoontorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrawadee","family":"Pitakpolrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supranee","family":"Buranapraditkun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunya","family":"Puttikhunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1965-5491","authenticated-orcid":false,"given":"Kieu","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Heyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7043-8062","authenticated-orcid":false,"given":"Chutitorn","family":"Ketloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiat","family":"Ruxrungtham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7446","key":"10.1016\/j.biopha.2026.119037_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119037_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2023.101205","article-title":"Dengue \"homegrown\" in Europe (2022\u20132023)","volume":"56","author":"Brem","year":"2024","journal-title":"New Microbes New Infect."},{"issue":"4","key":"10.1016\/j.biopha.2026.119037_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.meegid.2009.02.003","article-title":"Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease","volume":"9","author":"Weaver","year":"2009","journal-title":"Infect. Genet. Evol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119037_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00284-020-02284-w","article-title":"Current understanding of the pathogenesis of dengue virus infection","volume":"78","author":"Bhatt","year":"2021","journal-title":"Curr. Microbiol."},{"issue":"46","key":"10.1016\/j.biopha.2026.119037_bib5","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1016\/j.vaccine.2017.09.063","article-title":"Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence","volume":"35","author":"Sun","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2026.119037_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.coviro.2014.01.009","article-title":"Relating structure to evolution in class II viral membrane fusion proteins","volume":"5","author":"Modis","year":"2014","journal-title":"Curr. Opin. Virol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119037_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1574-695X.2000.tb01474.x","article-title":"Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis","volume":"28","author":"Chaturvedi","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.biopha.2026.119037_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2023.01.016","article-title":"Development of novel antiviral peptides against dengue serotypes 1-4","volume":"580","author":"Lee","year":"2023","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119037_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.146.1.201","article-title":"Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody","volume":"146","author":"Halstead","year":"1977","journal-title":"J. Exp. Med."},{"issue":"5979","key":"10.1016\/j.biopha.2026.119037_bib10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.biopha.2026.119037_bib11","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/CVI.00316-10","article-title":"How innate immune mechanisms contribute to antibody-enhanced viral infections","volume":"17","author":"Ubol","year":"2010","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.biopha.2026.119037_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.biopha.2026.119037_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.572681","article-title":"Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine","volume":"10","author":"Shukla","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.biopha.2026.119037_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.virusres.2016.12.003","article-title":"Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection","volume":"229","author":"Wang","year":"2017","journal-title":"Virus Res."},{"issue":"23","key":"10.1016\/j.biopha.2026.119037_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01181-17","article-title":"An envelope-modified tetravalent dengue virus-like-particle vaccine has implications for flavivirus vaccine Design","volume":"91","author":"Urakami","year":"2017","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119037_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00239-24","article-title":"A tetravalent dengue virus-like particle vaccine induces high levels of neutralizing antibodies and reduces dengue replication in non-human primates","volume":"98","author":"Thoresen","year":"2024","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119037_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"47","key":"10.1016\/j.biopha.2026.119037_bib18","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1016\/j.vaccine.2017.09.089","article-title":"Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age","volume":"35","author":"Halstead","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2026.119037_bib19","unstructured":"European Medicines Agency (EMA), Dengvaxia. Available from: \u3008https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/dengvaxia\u3009. Accessed 19 January 2025."},{"key":"10.1016\/j.biopha.2026.119037_bib20","series-title":"ACIP Evidence to Recommendations Framework for Dengvaxia","author":"Advisory Committee on Immunization Practices (ACIP)","year":"2021"},{"issue":"21","key":"10.1016\/j.biopha.2026.119037_bib21","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children and adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119037_bib22","article-title":"Current status of the development of dengue vaccines","volume":"22","author":"Lee","year":"2024","journal-title":"Vaccine X"},{"issue":"2","key":"10.1016\/j.biopha.2026.119037_bib23","article-title":"An update on self-amplifying mRNA vaccine development","volume":"9","author":"Blakney","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"10.1016\/j.biopha.2026.119037_bib24","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases - advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.biopha.2026.119037_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02482-20","article-title":"A dengue virus serotype 1 mRNA-LNP vaccine elicits protective immune responses","volume":"95","author":"Wollner","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2026.119037_bib26","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.omtm.2020.07.013","article-title":"Modified mRNA-LNP vaccines confer protection against experimental DENV-2 infection in mice","volume":"18","author":"Zhang","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.biopha.2026.119037_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA","volume":"15","author":"Baiersdorfer","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"5","key":"10.1016\/j.biopha.2026.119037_bib28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4269\/ajtmh.2009.08-0625","article-title":"Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: how alterations in assay conditions impact performance","volume":"81","author":"Thomas","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"7","key":"10.1016\/j.biopha.2026.119037_bib29","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s00253-018-8822-y","article-title":"Dengue viruses and promising envelope protein domain III-based vaccines","volume":"102","author":"Fahimi","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"10B","key":"10.1016\/j.biopha.2026.119037_bib30","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1101\/gr.2520504","article-title":"High-throughput expression of C. elegans proteins","volume":"14","author":"Luan","year":"2004","journal-title":"Genome Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119037_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jiph.2014.02.002","article-title":"Structural and functional analysis of hypothetical and conserved proteins of Clostridium tetani","volume":"7","author":"Enany","year":"2014","journal-title":"J. Infect. Public Health"},{"issue":"3","key":"10.1016\/j.biopha.2026.119037_bib32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1110\/ps.041009005","article-title":"Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli","volume":"14","author":"Idicula-Thomas","year":"2005","journal-title":"Protein Sci."},{"issue":"19","key":"10.1016\/j.biopha.2026.119037_bib33","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","article-title":"Protein-sol: a web tool for predicting protein solubility from sequence","volume":"33","author":"Hebditch","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2026.119037_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.biopha.2026.119037_bib35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.03.016","article-title":"Modified mRNA vaccines protect against zika virus infection","volume":"169","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119037_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52384","article-title":"Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics","volume":"8","author":"Durham","year":"2019","journal-title":"Elife"},{"issue":"7","key":"10.1016\/j.biopha.2026.119037_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010588","article-title":"Zika virus-like particle vaccine fusion loop mutation increases production yield but fails to protect AG129 mice against Zika virus challenge","volume":"16","author":"Thompson","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119037_bib38","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.ymthe.2022.01.013","article-title":"Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences","volume":"30","author":"Sankaradoss","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119037_bib39","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1038\/s41598-021-84733-5","article-title":"Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma","volume":"11","author":"Maeda","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119037_bib40","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1038\/ncomms4877","article-title":"A toggle switch controls the low pH-triggered rearrangement and maturation of the dengue virus envelope proteins","volume":"5","author":"Zheng","year":"2014","journal-title":"Nat. Commun."},{"issue":"50","key":"10.1016\/j.biopha.2026.119037_bib41","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1016\/j.vaccine.2015.09.112","article-title":"Mouse models of dengue virus infection for vaccine testing","volume":"33","author":"Sarathy","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.biopha.2026.119037_bib42","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.vaccine.2011.11.072","article-title":"Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice","volume":"30","author":"Brewoo","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biopha.2026.119037_bib43","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/s41467-023-37795-0","article-title":"Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice","volume":"14","author":"Prompetchara","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119037_bib44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/21645515.2018.1527496","article-title":"The effect of antigen dose on T cell-targeting vaccine outcome","volume":"15","author":"Billeskov","year":"2019","journal-title":"Hum. Vaccin Immunother."},{"issue":"6","key":"10.1016\/j.biopha.2026.119037_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005930","article-title":"Protection and polyfunctional T cells induced by Ag85B-TB10.4\/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose","volume":"4","author":"Aagaard","year":"2009","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.biopha.2026.119037_bib46","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1016\/j.vaccine.2011.03.002","article-title":"Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses","volume":"29","author":"Li","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biopha.2026.119037_bib47","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/JVI.02675-12","article-title":"Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection","volume":"87","author":"Rivino","year":"2013","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119037_bib48","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1128\/JVI.79.9.5665-5675.2005","article-title":"Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections","volume":"79","author":"Simmons","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2026.119037_bib49","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3389\/fimmu.2018.01196","article-title":"Structural influence on the dominance of virus-specific CD4 T cell epitopes in zika virus infection","volume":"9","author":"Koblischke","year":"2018","journal-title":"Front. Immunol."},{"issue":"57","key":"10.1016\/j.biopha.2026.119037_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg6461","article-title":"SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8(+) T cell responses","volume":"6","author":"Agerer","year":"2021","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119037_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41541-025-01088-y","article-title":"Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity","volume":"10","author":"Emmelot","year":"2025","journal-title":"NPJ Vaccin."},{"issue":"2","key":"10.1016\/j.biopha.2026.119037_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/femsre\/fuu004","article-title":"Receptors and routes of dengue virus entry into the host cells","volume":"39","author":"Cruz-Oliveira","year":"2015","journal-title":"FEMS Microbiol. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2026.119037_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/v14122776","article-title":"Comparative analysis of in vitro models to study antibody-dependent enhancement of zika virus infection","volume":"14","author":"Langerak","year":"2022","journal-title":"Viruses"},{"issue":"18","key":"10.1016\/j.biopha.2026.119037_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01023-18","article-title":"Engineered dengue virus domain III proteins elicit cross-neutralizing antibody responses in mice","volume":"92","author":"Frei","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2026.119037_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2019.02.002","article-title":"Structural perspectives of antibody-dependent enhancement of infection of dengue virus","volume":"36","author":"Morrone","year":"2019","journal-title":"Curr. Opin. Virol."},{"issue":"22","key":"10.1016\/j.biopha.2026.119037_bib56","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1007\/s00253-015-6819-3","article-title":"Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection","volume":"99","author":"Wang","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119037_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102991","article-title":"Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models","volume":"60","author":"Shukla","year":"2020","journal-title":"EBioMedicine"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:18:13Z","timestamp":1773991093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226000697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":57,"alternative-id":["S0753332226000697"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119037","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of DENV1 mRNA vaccines in mice: Toward improved neutralizing antibody and T cell responses","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119037"}}